↓ Skip to main content

American Association for Cancer Research

An AIB1 Isoform Alters Enhancer Access and Enables Progression of Early-Stage Triple-Negative Breast Cancer

Overview of attention for article published in Cancer Research, June 2021
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (96th percentile)
  • High Attention Score compared to outputs of the same age and source (97th percentile)

Mentioned by

news
7 news outlets
twitter
15 X users

Citations

dimensions_citation
12 Dimensions

Readers on

mendeley
13 Mendeley
Title
An AIB1 Isoform Alters Enhancer Access and Enables Progression of Early-Stage Triple-Negative Breast Cancer
Published in
Cancer Research, June 2021
DOI 10.1158/0008-5472.can-20-3625
Pubmed ID
Authors

Ghada M Sharif, Moray J Campbell, Apsra Nasir, Surojeet Sengupta, Garrett T Graham, Max H Kushner, William B Kietzman, Marcel O Schmidt, Gray W Pearson, Olivier Loudig, Susan Fineberg, Anton Wellstein, Anna T Riegel

X Demographics

X Demographics

The data shown below were collected from the profiles of 15 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 13 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 13 100%

Demographic breakdown

Readers by professional status Count As %
Lecturer > Senior Lecturer 1 8%
Student > Bachelor 1 8%
Student > Ph. D. Student 1 8%
Student > Master 1 8%
Professor > Associate Professor 1 8%
Other 0 0%
Unknown 8 62%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 3 23%
Veterinary Science and Veterinary Medicine 1 8%
Immunology and Microbiology 1 8%
Unknown 8 62%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 60. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 17 February 2022.
All research outputs
#616,650
of 23,146,350 outputs
Outputs from Cancer Research
#386
of 17,981 outputs
Outputs of similar age
#16,023
of 417,590 outputs
Outputs of similar age from Cancer Research
#8
of 256 outputs
Altmetric has tracked 23,146,350 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 97th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 17,981 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.8. This one has done particularly well, scoring higher than 97% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 417,590 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 96% of its contemporaries.
We're also able to compare this research output to 256 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 97% of its contemporaries.